Rice Hall James & Associates’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.52M | Sell |
53,979
-4,610
| -8% | -$301K | 0.19% | 121 |
|
|
2025
Q1 | $3.92M | Sell |
58,589
-379
| -0.6% | -$25.4K | 0.23% | 94 |
|
|
2024
Q4 | $3.26M | Sell |
58,968
-1,407
| -2% | -$77.8K | 0.18% | 130 |
|
|
2024
Q3 | $3.6M | Sell |
60,375
-297
| -0.5% | -$17.7K | 0.19% | 117 |
|
|
2024
Q2 | $3.86M | Sell |
60,672
-4,162
| -6% | -$265K | 0.23% | 96 |
|
|
2024
Q1 | $4.48M | Sell |
64,834
-86
| -0.1% | -$5.95K | 0.26% | 87 |
|
|
2023
Q4 | $3.58M | Sell |
64,920
-3,283
| -5% | -$181K | 0.21% | 113 |
|
|
2023
Q3 | $3.96M | Buy |
68,203
+20,760
| +44% | +$1.21M | 0.25% | 93 |
|
|
2023
Q2 | $2.55M | Buy |
+47,443
| New | +$2.55M | 0.14% | 155 |
|
|
2020
Q3 | – | Sell |
-27,526
| Closed | -$890K | – | 274 |
|
|
2020
Q2 | $890K | Sell |
27,526
-200
| -0.7% | -$6.47K | 0.04% | 216 |
|
|
2020
Q1 | $1.13M | Sell |
27,726
-217
| -0.8% | -$8.84K | 0.06% | 190 |
|
|
2019
Q4 | $1.72M | Sell |
27,943
-706
| -2% | -$43.5K | 0.06% | 187 |
|
|
2019
Q3 | $2.09M | Buy |
28,649
+2,335
| +9% | +$170K | 0.07% | 164 |
|
|
2019
Q2 | $2.16M | Sell |
26,314
-1,600
| -6% | -$132K | 0.07% | 168 |
|
|
2019
Q1 | $1.97M | Sell |
27,914
-1,225
| -4% | -$86.4K | 0.06% | 192 |
|
|
2018
Q4 | $1.31M | Buy |
29,139
+2,947
| +11% | +$133K | 0.05% | 230 |
|
|
2018
Q3 | $1.48M | Sell |
26,192
-6,186
| -19% | -$350K | 0.05% | 227 |
|
|
2018
Q2 | $2.16M | Buy |
+32,378
| New | +$2.16M | 0.08% | 191 |
|
|
2017
Q2 | – | Sell |
-32,426
| Closed | -$1.61M | – | 290 |
|
|
2017
Q1 | $1.61M | Sell |
32,426
-700
| -2% | -$34.6K | 0.08% | 218 |
|
|
2016
Q4 | $2.01M | Sell |
33,126
-200
| -0.6% | -$12.1K | 0.1% | 191 |
|
|
2016
Q3 | $2.21M | Buy |
+33,326
| New | +$2.21M | 0.12% | 164 |
|